|
|
Volumn 46, Issue 8, 2012, Pages 793-794
|
|
QTc prolongation and clozapine: Fact or artefact?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
COMORBIDITY;
GENETIC PREDISPOSITION;
HEART RATE;
HUMAN;
LETTER;
QT INTERVAL;
QT PROLONGATION;
SCHIZOPHRENIA;
T WAVE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MONITORING;
DRUG RESISTANCE;
DRUG SURVEILLANCE PROGRAM;
ELECTROCARDIOGRAPHY;
LONG QT SYNDROME;
METHODOLOGY;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
DRUG RESISTANCE;
ELECTROCARDIOGRAPHY;
HEART RATE;
HUMANS;
LONG QT SYNDROME;
PHARMACOVIGILANCE;
SCHIZOPHRENIA;
|
|
EID: 84871870373
PISSN: 00048674
EISSN: 14401614
Source Type: Journal
DOI: 10.1177/0004867412444625 Document Type: Letter |
|
Times cited : (8)
|
|
References (5)
|
